APL-1702 For Cervical HSIL: Post-Hoc Analysis of Long-Term Recurrence in a Global Multicenter Phase III Trial
Cervical high-grade squamous intraepithelial lesion (HSIL), a high-risk HPV-driven precancerous condition, has a 12-month postoperative recurrence rate of 26%. APL-1702, an innovative photodynamic therapy (PDT) combining hexyl aminolevulinate (5% HAL HCl) and LED light, provides a non-surgical treatment alternative. In this randomized, double-blind, international multicenter trial, 402 patients (2:1 randomization) received 1-2 treatments of APL-1702 or placebo within 6 months. HSIL 12-month recurrence was assessed through: response recurrence (12-month non-responders among 6-month responders) and histologic regression recurrence (12-month HSIL recurrence among 6-month histologic regression cases). Among the patients who completed 12-month follow-up without missing data, in the APL-1702 group, the response recurrence rate: 13.8% (CIN2: 17.1%; CIN3: 8.3%); the histologic regression recurrence rate: 13.2% (CIN2: 14.6%; CIN3: 10.7%). APL-1702 demonstrated lower 12-month recurrence rates, particularly in CIN3, supporting its potential as a non-surgical option with low-recurrence risk for HSIL patients.
Authors
- Chun Zhang (ORCID: https://orcid.org/0000-0001-9674-8627)
- Jingxin Cheng (ORCID: https://orcid.org/0000-0002-1608-7126)
- Qi Zhou (ORCID: https://orcid.org/0000-0001-7071-3178)
- Chenran Wang (ORCID: https://orcid.org/0000-0003-4181-2729)
- Limin Feng (ORCID: https://orcid.org/0000-0002-9857-7910)
- Yuan Wang (ORCID: https://orcid.org/0000-0002-7701-4561)
- Tianhua Qin
- Fei Chen (ORCID: https://orcid.org/0000-0002-4684-5733)
- Feng Wang (ORCID: https://orcid.org/0000-0003-1089-3095)
- Chunlin Chen (ORCID: https://orcid.org/0000-0003-3929-4707)
- Yi Chen (ORCID: https://orcid.org/0000-0001-7763-7016)
- T. Lin
- Hongqin Zhao
- Eileen He
Institutions
- Sun Yat-sen University (CN)
- Chongqing University (CN)
- Wenzhou Medical University (CN)
- Peking Union Medical College Hospital (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
- Beijing Tian Tan Hospital (CN)
- Maternal and Child Health Hospital of Xinjiang Uygur Autonomous Region (CN)
- Nanfang Hospital (CN)
- First People's Hospital of Foshan (CN)
- Fifth Affiliated Hospital of Sun Yat-sen University (CN)
- Wuxi Fourth People's Hospital (CN)
- Shanghai East Hospital (CN)
- Central Hospital of Wuhan (CN)
- Chongqing Cancer Hospital (CN)
- Tris Pharma (United States) (US)
Publication Details
- Journal
- Photodiagnosis and Photodynamic Therapy
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1016/j.pdpdt.2025.105157
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00